Abnormalities, Drug-Induced
"Abnormalities, Drug-Induced" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Congenital abnormalities caused by medicinal substances or drugs of abuse given to or taken by the mother, or to which she is inadvertently exposed during the manufacture of such substances. The concept excludes abnormalities resulting from exposure to non-medicinal chemicals in the environment.
| Descriptor ID |
D000014
|
| MeSH Number(s) |
C16.131.042
|
| Concept/Terms |
Abnormalities, Drug-Induced- Abnormalities, Drug-Induced
- Abnormalities, Drug Induced
- Drug-Induced Abnormalities
- Abnormality, Drug-Induced
- Drug Induced Abnormalities
- Drug-Induced Abnormality
|
Below are MeSH descriptors whose meaning is more general than "Abnormalities, Drug-Induced".
Below are MeSH descriptors whose meaning is more specific than "Abnormalities, Drug-Induced".
This graph shows the total number of publications written about "Abnormalities, Drug-Induced" by people in this website by year, and whether "Abnormalities, Drug-Induced" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 1 | 0 | 1 |
| 2003 | 2 | 0 | 2 |
| 2004 | 3 | 0 | 3 |
| 2005 | 3 | 0 | 3 |
| 2006 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 0 | 2 |
| 2011 | 0 | 2 | 2 |
| 2015 | 2 | 0 | 2 |
| 2016 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Abnormalities, Drug-Induced" by people in Profiles.
-
Kaplan S, Braverman DL, Frishman I, Bartov N. Pregnancy and Fetal Outcomes Following Exposure to Modafinil and Armodafinil During Pregnancy. JAMA Intern Med. 2021 02 01; 181(2):275-277.
-
Neogi SB, Negandhi PH, Gupta RK, Ganguli A, Zodpey S, Singh A, Gupta R. Authors' Reply to Sibel Y?ntem and Colleagues' Comment on "Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, India". Drug Saf. 2016 Jan; 39(1):91-2.
-
Neogi SB, Negandhi P, Chopra S, Das AM, Zodpey S, Gupta RK, Gupta R. Risk Factors for Stillbirth: Findings from a Population-Based Case-Control Study, Haryana, India. Paediatr Perinat Epidemiol. 2016 Jan; 30(1):56-66.
-
Neogi SB, Negandhi PH, Sandhu N, Gupta RK, Ganguli A, Zodpey S, Singh A, Singh A, Gupta R. Indigenous Medicine Use for Sex Selection During Pregnancy and Risk of Congenital Malformations: A Population-Based Case-Control Study in Haryana, India. Drug Saf. 2015 Sep; 38(9):789-97.
-
Brent RL. The role of the pediatrician in preventing congenital malformations. Pediatr Rev. 2011 Oct; 32(10):411-21; quiz 422.
-
Brent RL, Christian MS, Diener RM. Evaluation of the reproductive and developmental risks of caffeine. Birth Defects Res B Dev Reprod Toxicol. 2011 Apr; 92(2):152-87.
-
Brent RL. Reproductive toxicology. Reprod Toxicol. 2010 Apr; 29(2):251-3; author reply 254-5.
-
Anderka MT, Lin AE, Abuelo DN, Mitchell AA, Rasmussen SA. Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A. 2009 Jun; 149A(6):1241-8.
-
Gagne JJ, Maio V, Berghella V, Louis DZ, Gonnella JS. Prescription drug use during pregnancy: a population-based study in Regione Emilia-Romagna, Italy. Eur J Clin Pharmacol. 2008 Nov; 64(11):1125-32.
-
Crowley AR, Mehta SS, Hembree MJ, Preuett BL, Prasadan KL, Sharp SW, Yew H, McFall CR, Benjes CL, Tulachan SS, Gittes GK, Snyder CL. Faulty bone morphogenetic protein signaling in esophageal atresia with tracheoesophageal fistula. J Pediatr Surg. 2006 Jul; 41(7):1208-13.